GSE128915
Proteomics identifies a marker signature of MAPKi resistance in melanoma
Combined proteomic and RNAseq analysis on 6 melanoma cell cultures reveals a signature for resistance to MAPKi resistance. Overall design: 2 sensitive and 4 resistant melanoma cell cultures were RNAseqed